Statistiche di base
| Gestore | Mark N. Lampert |
| Profilo insider | BIOTECHNOLOGY VALUE FUND L P |
| Valore del portafoglio | $ 3.221.842.995 |
| Posizioni attuali | 55 |
| Posizioni attiviste | 37 |
Ultime partecipazioni, performance, AUM (da depositi 13F, 13D)
Depositi 13D/G
Questo è un elenco dei depositi 13D e 13G effettuati nell'ultimo anno (se presenti). Fai clic sull'icona del link per visualizzare la cronologia completa delle transazioni. Le righe verdi indicano le nuove posizioni. Le righe rosse indicano le posizioni chiuse.
| Data di deposito | Modulo | Titolo | Azioni precedenti |
Azioni attuali |
ΔAzioni % | % Proprietà |
% ΔProprietà | |
|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | XFOR / X4 Pharmaceuticals, Inc. | 2.258.400 | 2.243.659 | -0,65 | 9,90 | 421,05 | ||
| 2025-08-18 | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 2.438.964 | 9.611.751 | 294,09 | 5,60 | 211,11 | ||
| 2025-08-14 | VIGL / Vigil Neuroscience, Inc. | 4.734.500 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | UNCY / Unicycive Therapeutics, Inc. | 1.417.117 | 9,99 | |||||
| 2025-08-14 | VERV / Verve Therapeutics, Inc. | 6.904.050 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | CBIO / Crescent Biopharma, Inc. | 0 | 1.387.863 | 9,99 | ||||
| 2025-08-14 | ITOS / iTeos Therapeutics, Inc. | 3.075.000 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-08-14 | IMUX / Immunic, Inc. | 8.902.972 | 9.785.178 | 9,91 | 9,99 | 0,91 | ||
| 2025-08-13 | VSTM / Verastem, Inc. | 4.706.551 | 5.720.831 | 21,55 | 9,99 | 0,00 | ||
| 2025-08-07 | EPIX / ESSA Pharma Inc. | 8.748.629 | 11.668.473 | 33,37 | 24,70 | 25,38 | ||
| 2025-07-21 | OVID / Ovid Therapeutics Inc. | 3.853.818 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-07-09 | NKTR / Nektar Therapeutics | 1.276.595 | 7,40 | |||||
| 2025-07-09 | CTMX / CytomX Therapeutics, Inc. | 8.089.795 | 11.538.462 | 42,63 | 6,80 | -31,93 | ||
| 2025-06-16 | PTGX / Protagonist Therapeutics, Inc. | 2.970.427 | 3.211.041 | 8,10 | 5,20 | 6,12 | ||
| 2025-05-20 | XOMA / XOMA Royalty Corporation | 2.983.026 | 2.590.303 | -13,17 | 21,60 | -14,62 | ||
| 2025-05-19 | ALLK / Allakos Inc. | 16.552.417 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-05-15 | CDTX / Cidara Therapeutics, Inc. | 1.093.499 | 1.252.441 | 14,54 | 9,99 | 0,00 | ||
| 2025-05-15 | GHRS / GH Research PLC | 10.400.158 | 8.827.712 | -15,12 | 14,20 | -28,96 | ||
| 2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 4.834.297 | 4.632.749 | -4,17 | 9,99 | 0,00 | ||
| 2025-05-15 | ELEV / Elevation Oncology, Inc. | 6.230.845 | 4.440.000 | -28,74 | 7,00 | -29,93 | ||
| 2025-05-15 | GLUE / Monte Rosa Therapeutics, Inc. | 4.393.210 | 5.660.132 | 28,84 | 9,20 | 27,78 | ||
| 2025-05-15 | SEPN / Septerna, Inc. | 2.452.024 | 4.396.124 | 79,29 | 9,90 | 80,00 | ||
| 2025-05-15 | TCRX / TScan Therapeutics, Inc. | 5.073.003 | 5.263.541 | 3,76 | 9,99 | 0,00 | ||
| 2025-05-09 | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 8.545.499 | 8.545.499 | 0,00 | 6,10 | -32,22 | ||
| 2025-04-16 | THRD / Third Harmonic Bio, Inc. | 2.372.933 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2025-02-14 | FBRX / Forte Biosciences, Inc. | 2.982.105 | 643.622 | -78,42 | 9,99 | 21,83 | ||
| 2025-02-14 | ETNB / 89bio, Inc. | 6.811.631 | 4.333.885 | -36,38 | 3,60 | -43,75 | ||
| 2025-02-14 | AVTX / Avalo Therapeutics, Inc. | 967.299 | 1.038.542 | 7,37 | 9,99 | 0,00 | ||
| 2025-02-14 | TYRA / Tyra Biosciences, Inc. | 4.661.194 | 3.944.194 | -15,38 | 7,80 | -11,36 | ||
| 2025-02-14 | VTGN / Vistagen Therapeutics, Inc. | 2.777.245 | 3.084.324 | 11,06 | 9,97 | -0,20 | ||
| 2025-02-14 | IKNA / Ikena Oncology, Inc. | 4.769.164 | 4.006.564 | -15,99 | 8,30 | -16,16 | ||
| 2025-02-04 | KURA / Kura Oncology, Inc. | 4.212.346 | 5.912.554 | 40,36 | 7,50 | 38,89 | ||
| 2025-01-29 | ENGN / enGene Holdings Inc. | 3.196.439 | 945.402 | -70,42 | 1,80 | -75,00 | ||
| 2025-01-06 | RAPT / RAPT Therapeutics, Inc. | 11.764.000 | 8,70 | |||||
| 2024-12-17 | PVLA / Palvella Therapeutics, Inc. | 1.168.117 | 9,99 | |||||
| 2024-12-04 | OLMA / Olema Pharmaceuticals, Inc. | 9.135.893 | 7.557.237 | -17,28 | 9,99 | -40,18 | ||
| 2024-11-14 | MTEM / Molecular Templates, Inc. | 537.426 | 672.767 | 25,18 | 9,99 | 0,00 | ||
| 2024-11-14 | ACIU / AC Immune SA | 14.571.236 | 19.522.436 | 33,98 | 19,70 | 33,11 | ||
| 2024-11-14 | VIRX / Viracta Therapeutics, Inc. | 3.833.785 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | LXRX / Lexicon Pharmaceuticals, Inc. | 24.435.632 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | STRO / Sutro Biopharma, Inc. | 3.347.946 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | RGLS / Regulus Therapeutics Inc. | 9.661.235 | 883.844 | -90,85 | 1,30 | -86,99 | ||
| 2024-11-14 | ANTX / AN2 Therapeutics, Inc. | 1.563.963 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | ZYME / Zymeworks Inc. | 5.870.000 | 4.607.935 | -21,50 | 6,50 | -30,11 | ||
| 2024-11-14 | CGEM / Cullinan Therapeutics, Inc. | 4.393.321 | 5.796.433 | 31,94 | 9,99 | 0,00 | ||
| 2024-11-14 | JANX / Janux Therapeutics, Inc. | 4.579.818 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | IDYA / IDEAYA Biosciences, Inc. | 3.479.043 | 1.409.993 | -59,47 | 1,70 | -67,92 | ||
| 2024-11-14 | DCTH / Delcath Systems, Inc. | 2.338.426 | 1.041.667 | -55,45 | 3,60 | -63,96 | ||
| 2024-11-14 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 8.774.570 | 0 | -100,00 | 0,00 | -100,00 | ||
| 2024-11-14 | ANNX / Annexon, Inc. | 7.000.000 | 9.027.778 | 28,97 | 8,40 | -5,62 | ||
| 2024-11-14 | MIRM / Mirum Pharmaceuticals, Inc. | 4.370.024 | 3.075.907 | -29,61 | 6,40 | -31,91 | ||
| 2024-10-31 | ELDN / Eledon Pharmaceuticals, Inc. | 4.326.710 | 6.293.282 | 45,45 | 10,50 | -41,34 | ||
| 2024-10-29 | MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) | 8.696.205 | 9.888.592 | 13,71 | 24,50 | 2,51 | ||
| 2024-10-08 | MLTX / MoonLake Immunotherapeutics | 21.751.284 | 19.751.284 | -9,19 | 31,40 | -9,25 | ||
| 2024-09-11 | CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) | 6.260.311 | 0 | -100,00 | 0,00 | -100,00 |
